Crown Electrokinetics Corp. Common Stock
CRKN
CRKN was delisted on the 4th of March, 2025.
1 hedge funds and large institutions have $645K invested in Crown Electrokinetics Corp. Common Stock in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
71% less capital invested
Capital invested by funds: $2.19M → $645K (-$1.55M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BA
Bard Associates
Chicago,
Illinois
|
+$908K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$908K |
| 2 |
SC
Shay Capital
New York
|
-$369K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$26K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$6K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Citadel Advisors
Miami,
Florida
| – | -$26K | – | – |
|
|
27
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$2K | – | – |
|
|
SC
28
Shay Capital
New York
| – | -$369K | – | – |
|
|
29
UBS Group
Zurich,
Switzerland
| – | -$6K | – | – |
|
CRKN Hedge Fund Activity: Q3 2022 in Review
1 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Crown Electrokinetics Corp. Common Stock (CRKN) for Q3 2022, worth a combined $645K — down 71% from $2.19M a quarter earlier.
Fund positioning in CRKN was balanced in Q3 2022: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.
The largest buyer was Bard Associates, opening a new position worth an estimated $908K. The largest seller was Vanguard Group, exiting entirely with an estimated $908K sold.
- 1 institutional investor held Crown Electrokinetics Corp. Common Stock (CRKN) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $645K of Crown Electrokinetics Corp. Common Stock stock for Q3 2022, down 71% quarter-over-quarter.
- 1 fund opened new Crown Electrokinetics Corp. Common Stock positions in Q3 2022 and 1 closed out, a net change of 0 holders.
- The largest Crown Electrokinetics Corp. Common Stock buyer in Q3 2022 was Bard Associates, an estimated $908K added.
- The largest Crown Electrokinetics Corp. Common Stock seller in Q3 2022 was Vanguard Group, an estimated $908K sold.
Based on aggregated 13F filings for Q3 2022.